Breast Breaking News

Radiation therapy management in BRCA1/2 carriers diagnosed with earlybreast cancer: An international cohort study

Durvalumab in Combination With NeoadjuvantChemotherapy in Early Triple-Negative Breast Cancer:Long-Term Analysis From the GeparNuevo Trial

Palbociclib plus letrozole versus weekly paclitaxel, both in combinationwith trastuzumab plus pertuzumab, as neoadjuvant treatment for patientswith HR-positive/HER2-positive early breast cancer: primary results fromthe randomized phase II TOUCH trial (IBCSG 55-17)

Disparities in breast cancer incidence and survivalby age, race, and molecular subtype in US women

Phase II Clinical Study of Adebrelimab and BevacizumabCombined With Cisplatin/Carboplatin in Patients WithTriple-Negative Breast Cancer With Brain Metastases(ABC Study)

Lymph Node Ratioasan Independent Prognostic Factor in Breast Cancer: A Retrospective Studyof 4060 Patients Undergoing Axillary Lymph Node Dissection

The Pathologic Response Evaluation and Detection in Circulating Tumor-DNA Study: Ultrasensitive Circulating Tumor-DNA Assessment of Breast Cancer Minimal Residual Disease

Impact of Age on Use of Neoadjuvant Chemoimmunotherapyand Outcomes for Patients with Triple‑Negative Breast Cancer